Search results
Theriva Biologics Receives Fast Track Designation From FDA For VCN-01 For Treating Metastatic...
Benzinga· 6 days agoTheriva™ Biologics TOVX is an immuno-oncology company developing oncolytic viruses, otherwise known...
Anti-obesity drugs will be 2024’s defining trend
Pharmaceutical Technology via Yahoo Finance· 2 hours agoGlobalData’s latest update notes the impact of the growing anti-obesity market, personalised medicines, real-world evidence, and cell and gene therapies.
Small Business - Picayune Item | Picayune Item
The Picayune Item· 5 days agoCalyx / Invicro Forges a Strategic Collaboration with BAMF Health to Accelerate Clinical Translation of Radioligand Therapies and Immuno-Oncology Agents ...
This Needham biotech's stock has gone up 700% in 3 months - Boston Business Journal
The Business Journals· 2 days agoPaul Peter Tak, CEO of the immuno-oncology company, recently sat down with the Business Journal to...
Agenus (NASDAQ:AGEN) Stock Crosses Above 200-Day Moving Average of $12.95
ETF DAILY NEWS· 1 day agoAgenus Inc. (NASDAQ:AGEN – Get Free Report) passed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $12.95 and traded as high as $17.65.
AbbVie Announces Positive Topline Results from Phase 2 PICCOLO Trial Evaluating Mirvetuximab...
The Parsons Sun· 6 days agoPICCOLO trial met its primary endpoint of objective response rate (ORR)Data from the study will be presented at a future medical meeting
Fundraiser for Pelotonia to Take Place at the Downtown Exchange - WHIZ - Fox 5 / Marquee...
WHIZ News Zanesville· 20 hours agoJames Cancer Hospital and Richard J. Solove Research Institute, and the Pelotonia Institute for ...
State of Tennessee Treasury Department Boosts Position in Moderna, Inc. (NASDAQ:MRNA)
ETF DAILY NEWS· 8 hours agoState of Tennessee Treasury Department increased its holdings in Moderna, Inc. (NASDAQ:MRNA – Free Report) by 27.5% in the fourth quarter, according to its most recent Form 13F filing with the ...
Moderna's Investigational Therapeutic for Methylmalonic Acidemia (mRNA-3705) Selected by U.S. Food &...
Morningstar· 6 days agoCAMBRIDGE, MA / ACCESSWIRE / June 6, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced that the U.S. Food and Drug Administration (FDA) has selected mRNA-3705 for the Support for Clinical Trials ...
Moderna, Inc. (NASDAQ:MRNA) Insider Sells $766,810.02 in Stock
ETF DAILY NEWS· 7 hours agoModerna, Inc. (NASDAQ:MRNA – Get Free Report) insider Shannon Thyme Klinger sold 5,178 shares of the company’s stock in a transaction dated Monday, June 10th. Following the transaction, the ...
